Two patients sustained the rare complication of skin infarction following administration of intravenous streptokinase for acute myocardial infarction. We report evidence that dissolution of thrombus from an unsuspected source and subsequent microembolization of the skin may be responsible for this complication. In patients known to have an aortic aneurysm or ventricular thrombus, careful consid...

Acute Coronary Syndromes TIMI 14 (Final Results) Presenter: Elliott Antman, MD, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass. The study: A prospective, multicenter, randomized, controlled trial of combined therapy with thrombolytic agents and the platelet glycoprotein IIb/IIIa antagonist abciximab in patients with AMI. A total of 681 patients were randomized to standard...

streptokinase is a potent fibrinolytic agent which is widely used in treatment of deep vein thrombosis (dvt), pulmonary embolism (pe) and acute myocardial infarction (mi). major limitation of this enzyme is its short biological half-life in the blood stream. our previous report showed that complexing streptokinase with chitosan could be a solution to overcome this limitation. the aim of this re...